Literature DB >> 27296815

Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal.

Deolinda Silva1, Maria João Oliveira2, Miguel Guimarães2, Ricardo Lima2, Sílvia Gomes3, Susana Seixas4.   

Abstract

BACKGROUND: Alpha-1-antitrypsin deficiency (AATD) is a genetic condition caused by SERPINA1 mutations, which culminates into lower protease inhibitor activity in the serum and predisposes affected individuals to emphysema. Clinical manifestations of AATD are often associated to ZZ (p.Glu342Lys) and SZ (p.Glu264Val) genotypes and less frequently to rare deficiency or null alleles in heterozygous and homozygous states.
METHODS: We sequenced SERPINA1 (approximately 8 kb) and genotyped two microsatellites located upstream and downstream of the gene (195 and 5.6 kb, respectively) in a cohort of 51 AATD patients found to carry different rare alleles. A meta-analysis of SERPINA1 mutation spectrum was also performed.
RESULTS: We detected a total of 14 rare alleles including 3 defined by novel mutations (p.Glu162Gly, p.Arg281Lysfs*17 and p.Met374Leufs*19) and 11 characterized by previously described variants (c.-5+2dupT, p.Arg39Cys, p.Phe52del, p.Thr68Ile, p.Asp256Val, p.Leu263Pro, p.Glu264Val, p.Leu353Phefs*24, p.Pro369Ser and p.Pro369Leu) but in several instances differing in their molecular backgrounds. So far, SERPINA1 has 132 low-frequency variants (<1%), where AATD mutations are not evenly distributed across the three-dimensional structure and tend to cluster in functional domains like the gate or the shutter.
CONCLUSION: The contribution of rare SERPINA1 alleles into AATD should not be neglected in the diagnosis practice given there is a wide spectrum of variants originated by mutation and sometimes shuffled between chromosomes by recombination. Even though many of the rare variants are likely to be recent and population specific others seems to be as old as the Z allele and dispersed across European populations.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha-1-antitrypsin deficiency; Mutation recurrence; Null alleles; Rare variant distribution; Recombinant alleles

Mesh:

Substances:

Year:  2016        PMID: 27296815     DOI: 10.1016/j.rmed.2016.05.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

Review 1.  Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches.

Authors:  Auyon J Ghosh; Brian D Hobbs
Journal:  Expert Rev Respir Med       Date:  2022-01-13       Impact factor: 3.772

2.  Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update.

Authors:  Ignacio Blanco; Patricia Bueno; Isidro Diego; Sergio Pérez-Holanda; Francisco Casas-Maldonado; Cristina Esquinas; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-13

3.  Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.

Authors:  Friedrich Kueppers; Mark D Andrake; Qifang Xu; Roland L Dunbrack; Joannah Kim; Christopher L Sanders
Journal:  BMC Med Genet       Date:  2019-07-15       Impact factor: 2.103

Review 4.  New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.

Authors:  Joanna Chorostowska-Wynimko; Miriam Barrecheguren; Ilaria Ferrarotti; Timm Greulich; Robert A Sandhaus; Michael Campos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-02-12

Review 5.  Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.

Authors:  Susana Seixas; Patricia Isabel Marques
Journal:  Appl Clin Genet       Date:  2021-03-22

6.  A rare mutation on alpha-1 antitrypsin deficit and lung fibrosis: case report.

Authors:  Miguel Afonso; Clara Silva; Inês Pinho; Artur Vale; Ana Fernandes
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-12-16       Impact factor: 0.670

7.  The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém).

Authors:  Judith Bellemare; Nathalie Gaudreault; Kim Valette; Irene Belmonte; Alexa Nuñez; Marc Miravitlles; François Maltais; Yohan Bossé
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

8.  The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency Variant.

Authors:  Riccardo Ronzoni; Ilaria Ferrarotti; Emanuela D'Acunto; Alice M Balderacchi; Stefania Ottaviani; David A Lomas; James A Irving; Elena Miranda; Annamaria Fra
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

9.  Description of 22 new alpha-1 antitrypsin genetic variants.

Authors:  Céline Renoux; Marie-Françoise Odou; Guillaume Tosato; Jordan Teoli; Norman Abbou; Christine Lombard; Farid Zerimech; Nicole Porchet; Colette Chapuis Cellier; Malika Balduyck; Philippe Joly
Journal:  Orphanet J Rare Dis       Date:  2018-09-17       Impact factor: 4.123

10.  Liver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study.

Authors:  Murat Cakir; Elif Sag; Ali Islek; Masallah Baran; Gokhan Tumgor; Sema Aydogdu
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.